| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 955 | 2,121 | 896 | 2,199 | | Cost of Revenue | 303 | 739 | (2,280) | 832 | | | Gross Profit | 652 | 1,382 | 3,176 | 1,367 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 994 | 1,039 | 765 | 944 | | Non Recurring | 3,759 | (3,759) |
-
| 1,379 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (342) | 4,102 | 2,411 | (956) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,572 | 101 | 115 | 228 | | Earnings Before Interest And Taxes | 4,471 | 4,203 | 2,526 | (728) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 4,471 | 4,203 | 2,526 | (728) | | Income Tax Expense | 930 | 2,204 | 1,011 | (4,669) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,541 | 1,999 | 1,515 | 3,941 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,541 | 1,999 | 1,515 | 3,941 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,541 | $1,999 | $1,515 | $3,941 |
|
0.02% Nasdaq 0.00%
Income Statement
